We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current RLYB market cap is 57.47M. The company's latest EPS is USD -1.9720 and P/E is -0.77.
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -17.31M | -18.94M | -20.3M | -20.01M | -21.73M |
| Net Income | -16.2M | -17.32M | -18.63M | -18.37M | -20.24M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -17.75M | -26.83M | -47.15M | -68.96M | -80.97M |
| Net Income | -17.56M | -26.45M | -47.01M | -66.65M | -74.56M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 180.44M | 162.32M | 147.58M | 133.19M | 115.62M |
| Total Liabilities | 11.12M | 7.12M | 8.32M | 9.61M | 9.44M |
| Total Equity | 169.32M | 155.2M | 139.26M | 123.58M | 106.18M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 21.61M | 141.86M | 182.19M | 180.44M | 115.62M |
| Total Liabilities | 4.75M | 5.86M | 6.58M | 11.12M | 9.44M |
| Total Equity | -20.28M | -46.02M | 175.6M | 169.32M | 106.18M |
| Quarter End | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -57.28M | -18.77M | -32.15M | -48.62M | -60.27M |
| Investing | -112.17M | 1.47M | 7.68M | 10.75M | 27.66M |
| Financing | 51.08M | -139k | 71k | 71k | 143k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -15.03M | -22.04M | -45.53M | -57.28M | -60.27M |
| Investing | -188k | -2.07M | -2.33M | -112.17M | 27.66M |
| Financing | 31.57M | 144.89M | 82.97M | 51.08M | 143k |
| Market Cap | 57.47M |
| Price to Earnings Ratio | -0.77 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.35 |
| Price to Book Ratio | 0.54 |
| Dividend Yield | - |
| Shares Outstanding | 37.81M |
| Average Volume (1 week) | 134.92k |
| Average Volume (1 Month) | 191.84k |
| 52 Week Change | -80.86% |
| 52 Week High | 8.37 |
| 52 Week Low | 1.225 |
| Spread (Intraday) | 0.05 (3.27%) |
| Company Name | Rallybio Holdings LLC |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.rallybio.com. |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
